Novavax expects COVID vaccine targeting Omicron in fourth quarter

Novavax expects COVID vaccine targeting Omicron in fourth quarter Novavax Inc said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter as it accelerates development of shots to protect against the BA.4 and BA.5 subvariants. Reuters Reuters

...

The company's vaccine, based on an earlier strain of the virus, has not yet been authorized in the United States and is currently under U.S. Food and Drug Administration review.

...